Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.75% |
| 3 | Financials | 7.9% |
| 4 | Consumer Staples | 7.89% |
| 5 | Healthcare | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
751
Marsh
MRSH
$92.9B
| $1.15M | 0.01% |
18,925
-139,590
| -88% | -$7.82M |
|
752
Innoviva
INVA
$1.52B
| $1.15M | 0.01% |
+91,281
| New | +$1M |
|
753
Sturm, Ruger & Co
RGR
$615M
| $1.14M | 0.01% |
+16,604
| New | +$1.08M |
|
|
CELG
754
DELISTED
Celgene Corp
CELG
| $1.13M | 0.01% |
11,264
+8,028
| +248% | +$827K |
|
755
CALL
Hilton Worldwide
HLT
$74.3B
| $1.13M | 0.01% |
+16,667
| New | +$991K |
|
756
CALL
CEVA Inc
CEVA
$751M
| $1.13M | 0.01% |
+50,000
| New | +$1.04M |
|
757
Hartford Financial Services
HIG
$37.6B
| $1.12M | 0.01% |
24,364
-493,159
| -95% | -$20.7M |
|
758
Arcturus Therapeutics
ARCT
$408M
| $1.12M | 0.01% |
42,283
-62,761
| -60% | -$2.13M |
|
|
HAWK
759
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $1.11M | 0.01% |
+32,480
| New | +$1.18M |
|
760
FMC
FMC
$1.41B
| $1.08M | 0.01% |
30,873
-63,246
| -67% | -$2.05M |
|
761
Forum Energy Technologies
FET
$855M
| $1.06M | 0.01% |
4,036
+616
| +18% | +$138K |
|
|
HOT
762
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $1.06M | 0.01% |
12,700
-233,704
| -95% | -$15.9M |
|
|
WBMD
763
DELISTED
WebMD Health Corp.
WBMD
| $1.05M | 0.01% |
16,851
+2,451
| +17% | +$131K |
|
764
Altria Group
MO
$114B
| $1.05M | 0.01% |
16,820
-208,363
| -93% | -$12.6M |
|
|
GPT
765
DELISTED
Gramercy Property Trust
GPT
| $1.05M | 0.01% |
+41,419
| New | +$930K |
|
|
CALD
766
DELISTED
Callidus Software, Inc.
CALD
| $1.03M | 0.01% |
62,000
+30,530
| +97% | +$453K |
|
|
CCLP
767
DELISTED
CSI Compressco LP
CCLP
| $1.02M | 0.01% |
177,181
+95,950
| +118% | +$585K |
|
768
Sensient Technologies
SXT
$5.85B
| $1.01M | 0.01% |
+15,900
| New | +$935K |
|
|
AMAG
769
DELISTED
AMAG Pharmaceuticals
AMAG
| $1M | 0.01% |
42,895
-389,568
| -90% | -$9.25M |
|
|
PVTB
770
DELISTED
PrivateBancorp Inc
PVTB
| $995K | 0.01% |
25,774
-125,286
| -83% | -$4.59M |
|
771
Puma Biotechnology
PBYI
$471M
| $990K | 0.01% |
33,713
-229,573
| -87% | -$10.4M |
|
|
SGMO
772
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $990K | 0.01% |
163,697
-1,441,193
| -90% | -$8.65M |
|
773
LXP Industrial Trust
LXP
$3.6B
| $986K | 0.01% |
22,921
-320,634
| -93% | -$12.3M |
|
774
VeriSign
VRSN
$26.3B
| $984K | 0.01% |
11,110
+233
| +2% | +$19K |
|
775
Nomad Foods
NOMD
$1.69B
| $974K | 0.01% |
+108,053
| New | +$911K |
|
Similar funds
Dmitry Balyasny's Q1 2016 Portfolio in Review
As of Q1 2016, Dmitry Balyasny held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dmitry Balyasny deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Dmitry Balyasny's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Dmitry Balyasny added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Dmitry Balyasny's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Dmitry Balyasny fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Dmitry Balyasny's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Dmitry Balyasny opened 564 new positions and closed 526 in Q1 2016.
- Dmitry Balyasny's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.